ID

17933

Beskrivning

A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00201825

Länk

https://clinicaltrials.gov/show/NCT00201825

Nyckelord

  1. 2016-10-10 2016-10-10 -
Uppladdad den

10 oktober 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Lung Cancer NCT00201825

Eligibility Lung Cancer NCT00201825

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have advanced nsclc
Beskrivning

Non-Small Cell Lung Carcinoma Advanced

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
no prior chemotherapy
Beskrivning

Prior Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C1514457
eastern cooperative oncology group(ecog)performance status:0 or 1
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
must have measurable disease (recist criteria)
Beskrivning

Measurable Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C1513041
life expectancy of at least 12 weeks
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
adequate organ function including
Beskrivning

organ function

Datatyp

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
psychiatric disorders that would interfere w/consent or follow-up
Beskrivning

Mental disorders Interfere with Informed Consent | Mental disorders Interfere with Follow-up

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0021430
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C3274571
patients with uncontrolled diabetes mellitus, defined as random blood sugar > 250mg/dl.
Beskrivning

Diabetic - poor control | Random blood glucose level result

Datatyp

boolean

Alias
UMLS CUI [1]
C0421258
UMLS CUI [2]
C1261429

Similar models

Eligibility Lung Cancer NCT00201825

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced
Item
must have advanced nsclc
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Prior Chemotherapy
Item
no prior chemotherapy
boolean
C1514457 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group(ecog)performance status:0 or 1
boolean
C1520224 (UMLS CUI [1])
Measurable Disease
Item
must have measurable disease (recist criteria)
boolean
C1513041 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
organ function
Item
adequate organ function including
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Mental disorders Interfere with Informed Consent | Mental disorders Interfere with Follow-up
Item
psychiatric disorders that would interfere w/consent or follow-up
boolean
C0004936 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C3274571 (UMLS CUI [2,3])
Diabetic - poor control | Random blood glucose level result
Item
patients with uncontrolled diabetes mellitus, defined as random blood sugar > 250mg/dl.
boolean
C0421258 (UMLS CUI [1])
C1261429 (UMLS CUI [2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial